Website
News25/Ratings1
News · 26 weeks46-80%
2025-10-262026-04-19
Mix1790d
- Insider10(59%)
- SEC Filings4(24%)
- Earnings3(18%)
Latest news
25 items- INSIDERSEC Form 4 filed by Rudelius Robert James4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- INSIDERSEC Form 4 filed by A.L. Sarroff Fund, Llc4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 4 filed by Rudelius Robert James4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 4 filed by Ruben Joshua David4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 4 filed by Levitan Diane M4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 4 filed by Jasper Joseph William4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 4 filed by Costantino Robert J4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- INSIDERLarge owner A.L. Sarroff Fund, Llc bought 1,250,000 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Executive Officer Lai John was granted 72,282 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Financial Officer Lowenthal Garry N was granted 71,993 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- SECSEC Form 10-Q filed by PetVivo Holdings Inc.10-Q - PetVivo Holdings, Inc. (0001512922) (Filer)
- PRPetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026MINNEAPOLIS, MN, US, Feb. 17, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTC ID: PETVW)), and its wholly owned subsidiaries PetVivo Animal Health and PetVivo AI, a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported financial and operational results for the third quarter and first nine months of its fiscal year 2026 ended December 31, 2025. The company will hold a conference call today at 5:00 p.m. Eastern time to discuss the results and provide a business update, followed by a question-and-answer session (see dial-in information below). Fiscal Q3 Operational Highlights Signed an exclusive 10-ye
- PRPetVivo Issues Correction and Replacement Press Release; Sets Fiscal Third Quarter 2026 Conference Call for Tuesday, February 17, 2026 at 5:00 p.m. ETMINNEAPOLIS, MN, US, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., in collaboration with its wholly-owned subsidiary PetVivo Animal Health (OTCQX:PETV, OTCID: PETVW)), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, today announced that it is retracting and replacing its previously issued press release dated February 9, 2026 regarding the Company's fiscal third quarter 2026 conference call. This press release supersedes in its entirety the prior press release, which should no longer be relied upon. PetVivo will hold a conference call on Tuesday, February 17, 2026, at 5:00 p.m. Eastern Time to discuss resul
- PRPetVivo Sets Fiscal Third Quarter 2026 Conference Call for Monday, February 16, 2026 at 5:00 p.m. ETMINNEAPOLIS, MN, US, Feb. 09, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., including its wholly-owned subsidiary Petvivo Animal Health, Inc. (OTCQX:PETV, OTCID: PETVW)), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Monday, February 16, 2026 at 5:00 p.m. Eastern time to discuss results for the fiscal third quarter ended December 31, 2025. The financial results will be issued in a press release prior to the call. PetVivo management will host the presentation, followed by a question-and-answer period. The Fiscal Third Quarter 2026 conference call information is as follows: Date: Mond
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- NEWSDealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's EventATLANTIC CITY, NJ / ACCESS Newswire / January 23, 2026 / DealFlow Events today announced the growing list of companies scheduled to present and participate in one-on-one meetings with investors and analysts at the DealFlow Discovery Conference, taking place January 28-29, 2026, at the Borgata Hotel Casino & Spa in Atlantic City.More than 100 public and private companies are expected to participate in the conference, which brings together investors, analysts, growth company executives, and capital markets professionals for two days of company presentations, structured networking, and pre-scheduled 1:1 meetings.Below is the current list of companies confirmed to present and take meetings. Publ
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- PRPetVivo Holdings, Inc. Announces Health Canada Acknowledgement of Spryng® as a Veterinary Medical DeviceMINNEAPOLIS, MN, Jan. 21, 2026 (GLOBE NEWSWIRE) -- PetVivo Animal Health, Inc., in cooperation with its parent PetVivo Holdings, Inc. (OTCQX:PETV, OTCID: PETVW)) and affiliate PetVivo AI, Inc., an emerging biomedical device company focused on innovative medical technologies for companion animals and equine athletes, today announced that Health Canada has formally acknowledged Spryng® with OsteoCushion® Technology as a veterinary medical device for use in Canada. Spryng is a veterinarian-administered, intra-articular injectable device developed to support joint health and aid in the management of lameness and other joint-related afflictions in animals. This regulatory acknowledgement by He
- SECAmendment: SEC Form SCHEDULE 13G/A filed by PetVivo Holdings Inc.SCHEDULE 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)
- INSIDERSEC Form 5 filed by A.L. Sarroff Fund, Llc5 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 5 filed by A.L. Sarroff Fund, Llc5 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 5 filed by A.L. Sarroff Fund, Llc5 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERSEC Form 5 filed by A.L. Sarroff Fund, Llc5 - PetVivo Holdings, Inc. (0001512922) (Issuer)